Fortress Biotech, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2009 | 23.1% | 23.1% | — |
| FY2010 | 62.8% | 62.8% | -66.8% |
| FY2011 | -190.0% | -190.0% | -155.6% |
| FY2012 | -125.3% | -125.3% | -67.4% |
| FY2013 | -45.7% | -45.7% | -36.9% |
| FY2014 | -28.9% | -24.1% | -22.8% |
| FY2015 | -85.2% | -59.9% | -40.8% |
| FY2016 | -143.1% | -80.2% | -32.3% |
| FY2017 | -127.2% | -55.7% | -27.2% |
| FY2018 | -4,543.6% | -97.6% | -59.7% |
| FY2019 | -152.4% | -36.0% | -17.6% |
| FY2020 | -46.4% | -30.6% | -14.0% |
| FY2021 | -59.5% | -42.7% | -16.3% |
| FY2022 | -207.5% | -64.9% | -29.4% |
| FY2023 | -269.0% | -72.7% | -36.2% |
| FY2024 | -202.3% | -57.0% | -31.9% |
| FY2025 | 13.7% | 6.7% | 3.7% |